Urology · Park Ridge, IL
NPI
1942248794
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
350 S Northwest Hwy Ste 106
Park Ridge, IL, 60068
Phone (847) 470-1500
Groups this clinician bills Medicare through
Medicare paid, 2024
$867K
24,702 services
Medicare patients, 2024
1,865
Average age 77
Drug cost, 2024
$1.9M
6,378 prescriptions
Company payments, 2025
$1,217
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark T Brandt was code J0585 (injection, onabotulinumtoxina, 1 unit), 4,900 times for 13 patients. In total Mark T Brandt billed 24,702 services in 108 codes, and Medicare paid $867K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 4,900 | 13 | $4.98 | $24K |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 2,898 | 48 | $45.51 | $132K |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 2,500 | 11 | $2.30 | $5,747 |
| 99214 Office E&M - Established | Office | 1,857 | 1,329 | $92.28 | $171K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,794 | 1,290 | $12.43 | $22K |
| 81003 Clinical Chemistry | Office | 1,717 | 1,261 | $2.19 | $3,763 |
| 51798 Ultrasound - Nonspecific | Office | 1,576 | 1,249 | $8.60 | $14K |
| 99232 Hospital E&M - Subsequent | Facility | 569 | 280 | $65.09 | $37K |
| 52000 Cystourethroscopy | Office | 244 | 183 | $191.36 | $47K |
| 99215 Office E&M - Established | Office | 211 | 164 | $139.30 | $29K |
| 99222 Hospital E&M - Initial | Facility | 183 | 168 | $108.37 | $20K |
| 99204 Office E&M - New | Office | 146 | 146 | $115.08 | $17K |
| 52281 Calculus Removal - Urinary | Office | 112 | 76 | $254.53 | $29K |
| 76872 Ultrasound - Nonspecific | Office | 100 | 100 | $104.75 | $10K |
| 55700 Other Organ Systems | Office | 95 | 95 | $193.03 | $18K |
By year: 2022 $752K for 14,594 services; 2023 $768K for 17,830 services; 2024 $867K for 24,702 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,717 | 1,261 | $2.19 | $3,763 |
| 36415 Venipuncture Blood Collection | 12 | 12 | $8.65 | $104 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark T Brandt prescribed most often to Medicare patients was Finasteride, with 1,311 prescriptions and refills. In total Mark T Brandt wrote 6,378 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Finasteride Generic | 1,311 | 3,744 | 409 | $19K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 1,307 | 3,719 | 440 | $34K |
| Tamsulosin Hcl Generic | 1,084 | 2,970 | 375 | $20K |
| Dutasteride Generic | 298 | 887 | 101 | $11K |
| Myrbetriq Mirabegron | 205 | 464 | 76 | $205K |
| Hydrochlorothiazide Generic | 189 | 559 | 68 | $926 |
| Allopurinol Generic | 188 | 558 | 62 | $2,740 |
| Levofloxacin Generic | 171 | 171 | 149 | $388 |
| Gemtesa Vibegron | 152 | 328 | 50 | $159K |
| Methenamine Hippurate Generic | 149 | 384 | 68 | $19K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 116 | 318 | 35 | $2,409 |
| Xtandi Enzalutamide | 93 | 93 | 13 | $1.3M |
| Potassium Citrate Er Potassium Citrate | 88 | 242 | 32 | $10K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 83 | 83 | 75 | $208 |
| Bethanechol Chloride Generic | 73 | 155 | 25 | $4,295 |
Brand drugs: 505 claims; generic drugs: 5,873 claims; opioid claims: 93.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark T Brandt $1,217 ($1,217 in general payments such as food, travel and fees) from 25 companies. The largest payer was Pfizer Inc. with $236.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 9 | $236 |
| Immunitybio, Inc. IBRX | 4 | $109 |
| Abbvie Inc. ABBV | 4 | $78.49 |
| Janssen Biotech, Inc. JNJ | 3 | $70.07 |
| Urogen Pharma, Inc. URGN | 2 | $65.99 |
| Blue Earth Diagnostics | 2 | $58.79 |
| Accord Healthcare, Inc. | 3 | $57.01 |
| Procept Biorobotics Corporation PRCT | 2 | $50.93 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $48.37 |
| Smith+Nephew, Inc. SNN | 1 | $47.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.